
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL
Dai Maruyama, Takashi Watanabe, Akiko Miyagi Maeshima, Junko Nomoto, Hirokazu Taniguchi, Teruhisa Azuma, Masakazu Mori, Wataru Munakata, Sung-Won Kim, Yukio Kobayashi, Yoshihiro Matsuno, Kensei TobinaVolume:
92
Langue:
english
Pages:
12
DOI:
10.1007/s12185-010-0728-0
Date:
December, 2010
Fichier:
PDF, 265 KB
english, 2010